How menstrual cycle affects breast cancer in younger and older women
Part of Cancer, Skin clinical trials.
This study looks at two specific types of breast cancer in women diagnosed either before age 45 or after age 55. Researchers want to understand how a woman's hormonal cycle may affect how aggressive the cancer is and to find better ways to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have triple-negative breast cancer (cancer cells without hormone receptors) or hormone-receptor-positive, HER2-negative breast cancer
- You were diagnosed with breast cancer before age 45, or diagnosed at age 55 or older
- You have a tumor tissue sample available from your diagnosis that the study can examine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the timing of chemotherapy during your menstrual cycle affects how well it works in triple-negative breast cancer. Women with regular periods who are about to start chemo before surgery may be eligible.
This study looks at how age-related changes in your blood might affect how well your breast cancer treatment works. It includes people with hormone receptor-positive, HER2-negative breast cancer that has not spread to distant organs.
This trial looks at differences between younger and older breast cancer patients to better understand the disease. If you had breast cancer between the ages of 18 and 75 and were treated in a Chinese hospital from 2000 to 2024, you might be able to help.
This study looks at the potential harms and benefits of hormone (endocrine) therapy in people age 70 and older with early-stage, hormone-receptor–positive breast cancer. It may help doctors choose which hormone treatment approach is safest and most helpful for older patients.
This study looks at fertility, cancer outcomes, and children's health in women diagnosed with breast cancer at age 40 or younger. It aims to help you understand how breast cancer and its treatment may affect your ability to have children and your long-term health.
This study observes how doctors treat early breast cancer and what outcomes patients have. It's for people with hormone receptor-positive, HER2-negative breast cancer that hasn't spread to many lymph nodes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.